Kura Oncology updates CEO Troy Wilson severance terms in revised employment agreement
KURA•Revised executive employment agreements
Kura Oncology revised executive employment agreements for CEO Troy Wilson on July 24, 2026, then for CCO Brian Powl and COO Kathleen Ford on July 27.
Outside a corporate transaction window, severance shifts to 12 months base salary, up to 12 months COBRA premiums, and an option exercise period of up to 12 months.
Corporate transaction-related severance terms
Within 59 days before through 18 months post corporate transaction close, Wilson severance becomes 24 months salary, 200% target bonus, and equity acceleration.
In the same window, Powl and Ford severance becomes 18 months salary, 150% target bonus, and equity acceleration.
COBRA premium coverage extends to 24 months for Wilson, and 18 months for Powl and Ford, in corporate transaction-related terminations.
